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Positron emission tomography (PET) using the radiola-
beled glucose analogue 18F-FDG allows uncovering gly-
colysis processes within cancer cells and reveals high
value in diagnosis, staging, relapse and therapeutic
response evaluation in several malignancies. Breast can-
cer presents considerable variability when it comes to
18F-FDG uptake, which results in different sensitivity
and specificity values related to this technique. 18F-FDG
enters the cells through glucose transporters (GLUTs).
Therefore, this study aims to determine the pattern of
18F-FDG uptake in various breast cancer cell lines with
different hormonal and HER2 receptor’s expressions,
and to set a correlation with the expression of GLUT’s
1 and 3.
The studies were performed in three different human
breast cancer cell lines, MCF-7, HCC1806 and
HCC1954. MCF-7 express estrogen and progesterone
receptors (ER and PR), HCC1806 cells are triple nega-
tive and HCC1954 are negative for hormonal receptors,
but overexpress HER2/neu. GLUT-1 and GLUT-3
expressions were assessed by flow cytometry.
Our results show that, besides HCC1806 and
HCC1954 cells present higher GLUT-1 and GLUT-3
levels than MCF-7, we observe a higher 18F-FDG
uptake in HCC1954 cells. In fact, HCC1806 cells show
the lower 18F-FDG uptake comparing with other cell
lines.
These results suggest that despite the dependability of
GLUT-1 and GLUT-3 isoforms’ overexpression for 18F-
FDG uptake, these receptors do not seem to be the
unique responsible. Considering the absence of correla-
tion between GLUT’s expression and 18F-FDG uptake,
ER, PR and principally HER2/neu gains an apparent
relevance in this process.
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